Fuller H B Co: Form 10-Q for the period ended Sep 2, 2023
Filed with the SEC on Sep 28, 2023 and accepted by EDGAR at Sep 28, 2023, 15:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-06-04 to 2023-09-02 | $900.6m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2022-12-04 to 2023-09-02 | $2.61bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2023-06-04 to 2023-09-02 | $637.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-12-04 to 2023-09-02 | $1.87bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-06-04 to 2023-09-02 | $263.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-12-04 to 2023-09-02 | $735.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-06-04 to 2023-09-02 | $172.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-12-04 to 2023-09-02 | $493.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-06-04 to 2023-09-02 | $91.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-12-04 to 2023-09-02 | $241.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-06-04 to 2023-09-02 | $22.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-12-04 to 2023-09-02 | $51.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-06-04 to 2023-09-02 | $37.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-12-04 to 2023-09-02 | $99.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-06-04 to 2023-09-02 | $0.67 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-12-04 to 2023-09-02 | $1.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-06-04 to 2023-09-02 | $0.69 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-12-04 to 2023-09-02 | $1.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-06-04 to 2023-09-02 | 56,033,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-12-04 to 2023-09-02 | 55,890,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-12-04 to 2023-09-02 | $216.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-12-04 to 2023-09-02 | $109.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-12-04 to 2023-09-02 | $32.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-12-04 to 2023-09-02 | $2.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-02 | $94.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-02 | $1.24bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-02 | $4.66bn | us-gaap:Assets |
| Current liabilities | At period end2023-09-02 | $618.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-02 | $2.93bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-02 | $1.87bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2023-09-02 | $1.73bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-23-027018. Last ingested by Listed: Oct 26, 2026, 14:09 ET. Listed shows no prices and gives no investment advice.